Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255303 · ClinicalTrials.gov registry record · NA
Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT04255303: Completed NA study, sponsored by NYU Langone Health.
NCT04255303 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 347 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04255303, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
This study evaluates the effects of a novel integrated clinical prediction tool on antibiotic prescription patterns of nurses for acute respiratory infections (ARIs). The intervention is an EHR-integrated risk calculator and order set to help guide appropriate, evidence-based antibiotic prescriptions for patients presenting with ARI symptoms.
Primary Outcome
Participants will be interviewed to measure the usefulness of the iCPR tool in prescribing appropriate antibiotics.
Interventions
- OTHER Integrated clinical prediction rule (iCPR) system (iCPR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
What the finished NCT04255303 record still lists
NCT04255303 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which Integrated clinical prediction rule (iCPR) system (iCPR) is the first listed.
NCT04255303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04255303 about?
NCT04255303 is a clinical study titled "Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support". This study evaluates the effects of a novel integrated clinical prediction tool on antibiotic prescription patterns of nurses for acute respiratory infections (ARIs). The intervention is an EHR-integrated risk calculator and order set to help guide appropriate, evidence-based antibiotic prescription...
What is the current status of trial NCT04255303?
This trial is currently completed. It is a NA study. The enrollment target is 347 participants. The study started on 2022-02-23. Estimated completion is 2025-12-15.
What interventions are being tested in trial NCT04255303?
The interventions under investigation include: Integrated clinical prediction rule (iCPR) system (iCPR) (OTHER).
Who is sponsoring clinical trial NCT04255303?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04255303's enrollment target sits among peer trials
347 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI